These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2467380)

  • 1. Control of angiogenesis with synthetic heparin substitutes.
    Folkman J; Weisz PB; Joullié MM; Li WW; Ewing WR
    Science; 1989 Mar; 243(4897):1490-3. PubMed ID: 2467380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.
    Crum R; Szabo S; Folkman J
    Science; 1985 Dec; 230(4732):1375-8. PubMed ID: 2416056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.
    Li WW; Casey R; Gonzalez EM; Folkman J
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2898-905. PubMed ID: 1917393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.
    Chen NT; Corey EJ; Folkman J
    Lab Invest; 1988 Oct; 59(4):453-9. PubMed ID: 2459497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenesis inhibitor beta-cyclodextrin tetradecasulfate inhibits ecto-protein kinase activity.
    Skubitz KM; Ehresmann DD
    Cell Mol Biol; 1992 Sep; 38(6):543-60. PubMed ID: 1284648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiostatic steroids. Method of discovery and mechanism of action.
    Folkman J; Ingber DE
    Ann Surg; 1987 Sep; 206(3):374-83. PubMed ID: 2443088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat.
    Proia AD; Hirakata A; McInnes JS; Scroggs MW; Parikh I
    Exp Eye Res; 1993 Dec; 57(6):693-8. PubMed ID: 7512045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization.
    McNatt LG; Weimer L; Yanni J; Clark AF
    J Ocul Pharmacol Ther; 1999 Oct; 15(5):413-23. PubMed ID: 10530702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective effects of cyclodextrin on the local irritation induced by aqueous preparations of flurbiprofen].
    Masuda K; Ito A; Ikari T; Terashima A; Matsuyama T
    Yakugaku Zasshi; 1984 Oct; 104(10):1075-82. PubMed ID: 6530654
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of interfacial transfer and absorption behavior of drugs following dissolution from beta-cyclodextrin complexes.
    Uekama K; Uemura Y; Irie T; Otagiri M
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3637-43. PubMed ID: 6671224
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation (author's transl)].
    Uekama K; Matsuo N; Hirayama F; Ichibagase H; Arimori K; Tsubaki K; Satake K
    Yakugaku Zasshi; 1980 Sep; 100(9):903-9. PubMed ID: 7218151
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of angiogenesis by suramin.
    Gagliardi A; Hadd H; Collins DC
    Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of dimethyl beta-cyclodextrin on oral or rectal absorption of 1-hexylcarbamoyl-5-fluorouracil (HCFU)].
    Kikuchi M; Uekama K
    Yakugaku Zasshi; 1988 Feb; 108(2):156-63. PubMed ID: 3404404
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of tri-O-methyl-beta-cyclodextrin with drugs. II. Enhanced bioavailability of ketoprofen in rats when administered with tri-O-methyl-beta-cyclodextrin.
    Nakai Y; Yamamoto K; Terada K; Horibe H; Ozawa K
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3745-7. PubMed ID: 6671012
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
    Seo H; Tsuruoka M; Hashimoto T; Fujinaga T; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):286-91. PubMed ID: 6850944
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of angiogenesis by aurintricarboxylic acid.
    Gagliardi AR; Collins DC
    Anticancer Res; 1994; 14(2A):475-9. PubMed ID: 7517120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of beta- and dimethyl beta-cyclodextrins on release and percutaneous absorption behaviors of prednisolone from some ointment bases].
    Uekama K; Masaki K; Arimori K; Irie T; Hirayama F
    Yakugaku Zasshi; 1987 Jun; 107(6):449-56. PubMed ID: 3681663
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction in the local tissue toxicity of chlorpromazine by beta-cyclodextrin complexation.
    Irie T; Kuwahara S; Otagiri M; Uekama K; Iwamasa T
    J Pharmacobiodyn; 1983 Oct; 6(10):790-2. PubMed ID: 6663444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity of fibroblast growth factors for beta-cyclodextrin tetradecasulfate.
    Yuen SN; Folkman J; Weisz PB; Joullie MM; Ewing WR
    Anal Biochem; 1990 Feb; 185(1):108-11. PubMed ID: 2344037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.